Sofinnova Investments

Sobre

Sofinnova Investments is a clinical-stage biopharmaceutical venture firm that partners with entrepreneurs developing transformative medicines. It combines investment experience with drug-development and operating expertise and has approximately $2B in assets under management and committed capital.

Sectores

• Ciencias de la vida

Inversiones destacadas

• Natera
• Seattle Genetics
• Amarin
• Aerie Pharmaceuticals
• Rapport Therapeutics
• BioAge Labs
• ArriVent

Inversores

• Chris CarpenterExecutive Partner, Private Equity→
• Eric HsuAnalyst, Private Equity→
• Jakob DupontExecutive Partner, Private Equity→
• Jim HealyManaging Partner→
• Jonathan LeffExecutive Partner, Private Equity→
• Lars EkmanExecutive Partner, Private Equity→
• Maha KatabiGeneral Partner→
• Maha RadhakrishnanExecutive Partner, Private Equity→
• Mike VanAssociate, Private Equity→
• Naomi PacalinAssociate, Private Equity→

Cómo contactarlos

deals@sofinnova.com